Page last updated: 2024-10-21

1-anilino-8-naphthalenesulfonate and Polyneuropathies

1-anilino-8-naphthalenesulfonate has been researched along with Polyneuropathies in 2 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Polyneuropathies: Diseases of multiple peripheral nerves simultaneously. Polyneuropathies usually are characterized by symmetrical, bilateral distal motor and sensory impairment with a graded increase in severity distally. The pathological processes affecting peripheral nerves include degeneration of the axon, myelin or both. The various forms of polyneuropathy are categorized by the type of nerve affected (e.g., sensory, motor, or autonomic), by the distribution of nerve injury (e.g., distal vs. proximal), by nerve component primarily affected (e.g., demyelinating vs. axonal), by etiology, or by pattern of inheritance.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Singh, S1
Kamat, SS1
Kluge, H1
Wieczorek, V1

Other Studies

2 other studies available for 1-anilino-8-naphthalenesulfonate and Polyneuropathies

ArticleYear
The loss of enzymatic activity of the PHARC-associated lipase ABHD12 results in increased phagocytosis that causes neuroinflammation.
    The European journal of neuroscience, 2021, Volume: 54, Issue:10

    Topics: Animals; Ataxia; Lipase; Mice; Monoacylglycerol Lipases; Phagocytosis; Polyneuropathies

2021
[Lipase activities in the cerebrospinal fluid].
    Psychiatrie, Neurologie, und medizinische Psychologie, 1968, Volume: 20, Issue:9

    Topics: Adult; Atrophy; Brain Diseases; Brain Neoplasms; Central Nervous System Diseases; Clinical Enzyme Te

1968